The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these ...
More

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.
To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come.Less

Prescription for Change : The Looming Crisis in Drug Development

Michael Kinch

Published in print: 2016-11-07

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.
To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come.

Research-to-Revenue: A Practical Guide to University Startups is an essential field guide for navigating the murky waters of university spinouts. It combines the theory and practice of translating ...
More

Research-to-Revenue: A Practical Guide to University Startups is an essential field guide for navigating the murky waters of university spinouts. It combines the theory and practice of translating ground-breaking university research into high-impact products. Books on entrepreneurship abound but few address the unique aspects of a university startup, namely the importance of intellectual property, the technical and market risks of developing technology-based products, and the role of the faculty and university in the startup. The heart of the book are the 18 Key Steps to a Startup, from recognizing the university research-based business opportunity to recruiting the management team to writing the business plan. Each step is described in practical terms, based on the authors’ experiences in launching university startups. These steps are further reinforced by three case studies, each described in terms of the steps. The book concludes with a section for key stakeholders: research faculty, business leaders, and university administrators. For aspiring faculty entrepreneurs and business leaders, practical advice and lessons learned are provided from faculty founders and entrepreneurs who have “been there, done that”. The book is accompanied by the ResearhToRevenue.com website where readers can access business documents, grant applications, and other practical resources.Less

Research To Revenue : A Practical Guide to University Start-Ups

Don RoseCam Patterson

Published in print: 2016-01-15

Research-to-Revenue: A Practical Guide to University Startups is an essential field guide for navigating the murky waters of university spinouts. It combines the theory and practice of translating ground-breaking university research into high-impact products. Books on entrepreneurship abound but few address the unique aspects of a university startup, namely the importance of intellectual property, the technical and market risks of developing technology-based products, and the role of the faculty and university in the startup. The heart of the book are the 18 Key Steps to a Startup, from recognizing the university research-based business opportunity to recruiting the management team to writing the business plan. Each step is described in practical terms, based on the authors’ experiences in launching university startups. These steps are further reinforced by three case studies, each described in terms of the steps. The book concludes with a section for key stakeholders: research faculty, business leaders, and university administrators. For aspiring faculty entrepreneurs and business leaders, practical advice and lessons learned are provided from faculty founders and entrepreneurs who have “been there, done that”. The book is accompanied by the ResearhToRevenue.com website where readers can access business documents, grant applications, and other practical resources.

PRINTED FROM UNIVERSITY OF NORTH CAROLINA PRESS SCHOLARSHIP ONLINE (www.northcarolina.universitypressscholarship.com). (c) Copyright University of North Carolina Press, 2017. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in CSO for personal use (for details see http://www.northcarolina.universitypressscholarship.com/page/privacy-policy).date: 19 March 2018